Hanmi Pharmaceutical secureda patent for an inhalation asthma and COPD treatment ‘Fluterol’

Hanmi Pharmaceutical (executive director Kwan-soon Lee)made a public announcement aboutacquisition of domestic patent on the self-developed inhalation asthma and COPD treatment ‘Fluterol’.

Fluterol is a drug installedin a specially designed capsule to inhale; the technology maximized drug effectiveness and complianceof patients as it deeply deliversthe drug into lungs no matter what age and se...